PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

Eva Verheij  ¹     Sanne van Munster  ^{1, 2}     Cary C. Cotton  ³     Özge Ozdemir  ³     Esther Toes-Zoutendijk  ⁴     Esther A. Nieuwenhuis  ^{1, 2}     Iris Lansdorp-Vogelaar  ²     Bas L.A.M. Weusten  ^{2, 5}     Lorenza Alvarez Herrero  ⁵     Alaa Alkhalaf  ⁶     B. Ed Schenk  ⁶     Erik Jan Schoon  ⁷     Wouter L. Curvers  ⁷     Arjun D. Koch  ⁷     Pieter Jan de Jonge  ⁷     Thjon J. Tang  ⁸     Wouter B. Nagengast  ⁹     Jessie Westerhof  ⁹     Martin Houben  ¹⁰     Nicholas J. Shaheen  ¹⁰     Jacques J. Bergman  ¹⁰     Roos E. Pouw  ^10    
1 Amsterdam University Medical Centers, Amsterdam, Netherlands
² St Antonius Hospital, Nieuwegein, Netherlands
³ University of North Carolina School of Medicine, Chapel Hill, United States
⁴ Erasmus MC University Medical Center, Rotterdam, Netherlands
⁵ University Medical Center Utrecht, Utrecht, Netherlands
⁶ Isala Hospital, Zwolle, Netherlands
⁷ Catharina Hospital, Eindhoven, Netherlands
⁸ IJsselland Hospital, Capelle aan den IJssel, Netherlands
⁹ University Medical Center Groningen, Groningen, Netherlands
¹⁰ Haga Teaching Hospital, The Hague, Netherlands

Topic
Oesophagus

Session
Upper GI endoscopy and neoplasia (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)